From: Evaluation of two sexual-stage antigens as bivalent transmission-blocking vaccines in rodent malaria
Mouse | Immunization group | Oocyst density mean (range) (n = 180) | TRAa | Prevalence of infection mean (n = 180) | TBAb |
---|---|---|---|---|---|
Mouse 1–6 | Control | 130.6 (0–254) |  | 94.4% (170/180) |  |
Trx-His | 129.4 (0–254) |  | 95.6% (172/180) |  | |
Pbg37 | 66.8 (0–224) | 48.4% | 92.2% (166/180) | 3.4% | |
PSOP25 | 48.7 (0–167) | 62.3% | 82.8% (149/180) | 12.8% | |
Pbg37+PSOP25 | 32.4 (0–138) | 74.9% | 80.0% (144/180) | 15.6% | |
Pbg37-PSOP25 | 29.7 (0–140) | 77.0% | 76.1% (137/180) | 19.5% |